Berry Genomics Co.,Ltd (SHE:000710)
10.60
0.00 (0.00%)
May 19, 2026, 10:25 AM CST
Berry Genomics Co.,Ltd Market Cap
Berry Genomics Co.,Ltd has a market cap or net worth of 3.75 billion as of May 18, 2026. Its market cap has decreased by -23.13% in one year.
Market Cap
3.75B
Enterprise Value
3.76B
Revenue
922.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
10.60
Market Cap Chart
Since June 20, 2017, Berry Genomics Co.,Ltd's market cap has decreased from 24.43B to 3.75B, a decrease of -84.66%. That is a compound annual growth rate of -18.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 3.68B | -7.79% |
| Dec 31, 2025 | 3.99B | 33.61% |
| Dec 31, 2024 | 2.99B | -26.65% |
| Dec 29, 2023 | 4.07B | 0.96% |
| Dec 30, 2022 | 4.03B | -40.71% |
| Dec 31, 2021 | 6.80B | -49.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 20, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amoy Diagnostics | 7.83B |
| Beijing Strong Biotechnologies,Inc. | 7.64B |
| Maccura Biotechnology Co.Ltd | 6.25B |
| Cowealth Medical China | 5.76B |
| Thalys Medical Technology Group | 4.47B |
| Shanghai Labway Clinical Laboratory | 4.24B |
| Guangdong Hybribio Biotech | 3.96B |
| Medicalsystem Biotechnology | 3.85B |